Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 03, 2025 04:39 ET | Source: Research and Markets

State of the Biopharmaceutical Industry, Mid Year 2025 Report - Vanzacaftor Calcium + Deutivacaftor + Tezacaftor for Cystic Fibrosis is Expected to Have the Highest Commercial Success

Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition" report has been added to ResearchAndMarkets.com's offering. The report...
June 17, 2025 10:00 ET | Source: Medicovestor Inc

FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer

FDA grants Orphan Drug Designation to Medicovestor’s ADoBind MC001, a novel ADC targeting hard-to-treat pancreatic cancer.
May 26, 2025 10:00 ET | Source: Exactitude Consultancy

Antibody Drug Conjugates (ADCs) Contract Manufacturing Market to Reach USD 7.5 Billion by 2034, Growing at 7.2% CAGR | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, May 26, 2025 (GLOBE NEWSWIRE) -- The global Antibody Drug Conjugates (ADCs) Contract Manufacturing Market is projected to grow from USD 3.8 billion in 2024 to...
May 20, 2025 04:16 ET | Source: Research and Markets

Global Antibody Drug Conjugates Market Report 2025-2035: North America Leads ADC Market Growth with Strong Infrastructure and Innovations

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market - 2025-2035: Focus on Product, Application, Target, Payload Type, Linker Type, Linker Technology, and Geography"...
May 19, 2025 11:27 ET | Source: Research and Markets

Europe Contract Research Organization Market Size and Forecast Report 2025-2031: Stiff Competition and Pricing Pressures Hampering Growth

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Europe Contract Research Organization Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type,...
April 25, 2025 04:23 ET | Source: Research and Markets

Antibody Drug Conjugates Market and Forecast to 2030: Trends, Developments and Shares by Type of ADC, Application, Region and Company

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 18, 2025 10:21 ET | Source: Research and Markets

Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Antibody-drug conjugates" has been added to ResearchAndMarkets.com's offering. ntibody-drug conjugates (ADCs) are redefining...
April 15, 2025 17:27 ET | Source: Radiance BioPharma

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies

BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today...
April 10, 2025 05:59 ET | Source: Research and Markets

Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biopharmaceuticals market is...
April 07, 2025 06:19 ET | Source: Research and Markets

Cancer Therapeutics Market to Reach $168 Billion by 2029 Driven by Metastatic and Recurrent Cancer Innovations

Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions" report has been added to ResearchAndMarkets.com's offering. Both...

Next Page keyboard_arrow_right